Bogart Wealth LLC’s Ionis Pharmaceuticals IONS Stock Holding History

Bogart Wealth LLC’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.75K	Hold	123	–	–	﹤0.01%	1012
2026 Q1	$9.24K	Sell	123 -5	-4%	-$395	﹤0.01%	924
2025 Q4	$10.1K	Buy	128 +10	+8%	+$753	﹤0.01%	863
2025 Q3	$7.72K	Hold	118	–	–	﹤0.01%	879
2025 Q2	$4.66K	Buy	118 +16	+16%	+$524	﹤0.01%	951
2025 Q1	$3.08K	Buy	102 +31	+44%	+$1.01K	﹤0.01%	1002
2024 Q4	$2.48K	Hold	71	–	–	﹤0.01%	1061
2024 Q3	$2.84K	Sell	71 -14	-16%	-$651	﹤0.01%	920
2024 Q2	$4.05K	Hold	85	–	–	﹤0.01%	828
2024 Q1	$3.69K	Hold	85	–	–	﹤0.01%	824
2023 Q4	$4.3K	Hold	85	–	–	﹤0.01%	780
2023 Q3	$3.86K	Hold	85	–	–	﹤0.01%	781
2023 Q2	$3.49K	Hold	85	–	–	﹤0.01%	793
2023 Q1	$3.04K	Hold	85	–	–	﹤0.01%	835
2022 Q4	$3.21K	Hold	85	–	–	﹤0.01%	740
2022 Q3	$4K	Hold	85	–	–	﹤0.01%	725
2022 Q2	$3K	Buy	85 +55	+183%	+$2.07K	﹤0.01%	725
2022 Q1	$1K	Sell	30 -70	-70%	-$2.29K	﹤0.01%	741
2021 Q4	$3K	Sell	100 -25	-20%	-$787	﹤0.01%	615
2021 Q3	$4K	Hold	125	–	–	﹤0.01%	563
2021 Q2	$5K	Hold	125	–	–	﹤0.01%	518
2021 Q1	$6K	Buy	125 +100	+400%	+$5.58K	﹤0.01%	458
2020 Q4	$1K	Buy	+25	New	+$1.25K	﹤0.01%	434

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bogart Wealth LLC's IONS Position: Q2 2026 in Review

Bogart Wealth LLC held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 123 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Bogart Wealth LLC first reported a position in IONS in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.1K in Q4 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Bogart Wealth LLC held 123 shares of Ionis Pharmaceuticals worth $9.75K as of Q2 2026.
Bogart Wealth LLC left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1012 holding.
Bogart Wealth LLC first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Bogart Wealth LLC's Ionis Pharmaceuticals position peaked at $10.1K in Q4 2025.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.